Lykos’ MDMA therapy to go before FDA committee; GSK expands work with BioVersys
Plus, news about Eledon and Travere Therapeutics:
Lykos Therapeutics’ MDMA therapy gets an adcomm date: An FDA advisory committee is scheduled to
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
